Search
Search Results
##search.searchResults.foundPlural##
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3427PDF: 2014HTML: 7570 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4201Suppl. Files: 1199PDF: 1115Html: 247 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5282PDF: 1366HTML: 2863Cover letter: 216 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
5064PDF: 1341HTML: 1928Untitled: 195Untitled: 191 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3846PDF: 1629HTML: 8210Randi Fig: 197 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2250PDF: 1648HTML: 432 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2424PDF: 1889HTML: 158 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1448PDF: 578HTML: 229 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2046PDF: 756HTML: 716Table1: patient's characteristics: 167Table 2: profile of each patient: 191 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1079PDF: 572HTML: 7880 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1849PDF: 737HTML: 425 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1351PDF: 481HTML: 18620Figure 1: 179Figure 2: 160Figure 3: 177Figure 4: 215Figure 5: 188 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2648PDF: 832HTML: 5361 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3209PDF: 1165HTML: 1680Untitled: 189Untitled: 184Untitled: 183 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3402PDF: 810HTML: 3017Figure 1a and 1b: 165Figure 2: 172Figure 3: 191Figure 4: 172Figure 5: 175Tables 1-5: 161 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2893PDF: 1168HTML: 11407 -
-
TYROSINE KINASE INHIBITORS AND INTERFERON
2931PDF: 1463HTML: 3089Cover Letter: 224 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1741PDF: 1295HTML: 551 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12799PDF: 1712HTML: 4346Cover letter: 212Figure 1: 221 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5302PDF: 1553HTML: 1656Untitled: 247 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3304PDF: 1048HTML: 2280 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3108PDF: 1039HTML: 3187 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2406PDF: 1205HTML: 985 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1229PDF: 783HTML: 1527Figure 1: 214Figure 2: 206 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1962PDF: 808HTML: 558 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1925PDF: 431HTML: 226 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1635PDF: 1083HTML: 429







